Netherlands
# |
Name |
Market Capitalization |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 40.78 B |
Feb. 5, 2025 | USD 667.09 | 1.81% |
|
Netherlands |
|
2 |
USD 2.85 B |
Jan. 31, 2025 | USD 40.94 | -1.52% |
|
Netherlands |
|
3 |
USD 2.39 B |
Jan. 31, 2025 | USD 22.29 | 2.39% |
|
Netherlands |
|
4 |
USD 961.55 M |
Jan. 31, 2025 | USD 17.60 | -0.73% |
|
Netherlands |
|
5 |
USD 25.77 M |
Jan. 14, 2025 | USD 0.98 | -1.01% |
|
Netherlands |
The Vaccines company in Netherlands with the highest Market Capitalization is argenx SE (Brussels Stock Exchange: ARGX.BR) at USD 40.78 B.
The Vaccines company in Netherlands with the lowest Market Capitalization is LAVA Therapeutics N.V. (NasdaqGS: LVTX) at USD 25.77 M.
The top 10 Vaccines companies in Netherlands by Market Capitalization are argenx SE, Merus N.V., NewAmsterdam Pharma Company N.V., Pharvaris N.V. and LAVA Therapeutics N.V..
The bottom 10 Vaccines companies in Netherlands by Market Capitalization are LAVA Therapeutics N.V., Pharvaris N.V., NewAmsterdam Pharma Company N.V., Merus N.V. and argenx SE.